Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Medtronic
Accenture
Julphar
Cipla
McKesson
Dow
Healthtrust
Citi

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,676,930

« Back to Dashboard

Summary for Patent: 5,676,930
Title: Stabilized medicinal aerosol solution formulations
Abstract:Stabilized medicinal aerosol solution formulations comprising medicaments that degrade or decompose by interaction with solvents or water, an HFC propellant, a cosolvent and an acid are described. Further, specific medicinal aerosol solution formulations comprising ipratropium bromide or fenoterol, ethyl alcohol, 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane, and either an inorganic acid or an organic acid are described. The acids are present in amounts sufficient to reduce the degradation of the medicaments to acceptable levels.
Inventor(s): Jager; Paul Donald (Waterbury, CT), Kontny; Mark James (New Milford, CT), Nagel; Jurgen Hubert (Ingelheim/Rhein, DE)
Assignee: Boehringer Ingelheim Pharmaceuticals, Inc. (Ridgefield, CT)
Application Number:08/475,060
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;

Drugs Protected by US Patent 5,676,930

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,676,930

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1095265 ➤ Try a Free Trial
China 1054282 ➤ Try a Free Trial
Czech Republic 9501490 ➤ Try a Free Trial
Czech Republic 284203 ➤ Try a Free Trial
Germany 69324161 ➤ Try a Free Trial
Denmark 0673240 ➤ Try a Free Trial
European Patent Office 0673240 ➤ Try a Free Trial
Spain 2129117 ➤ Try a Free Trial
Finland 952842 ➤ Try a Free Trial
Finland 114283 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Argus Health
Healthtrust
Accenture
Chubb
Queensland Health
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot